Division of Urology, Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Regione Gonzole 10, Orbassano, 10043, Turin, Italy.
Virginia Commonwealth University, Richmond, VA, USA.
World J Urol. 2018 Feb;36(2):201-207. doi: 10.1007/s00345-017-2126-1. Epub 2017 Nov 10.
To test the face and content validity of 3D virtual-rendered printed models used before robot-assisted prostate cancer and nephron-sparing surgery.
Patients who underwent live surgery during an international urological meeting organized in January 2017 were enrolled. Those with organ-confined prostate cancer underwent robot-assisted radical prostatectomy. Patients with a single renal tumor underwent minimally invasive nephron-sparing surgery. High-resolution (HR) imaging was obtained for all patients. Those with kidney tumors received contrast-enhanced CT scan with angiography; those with prostate cancer underwent mp-MRI. Images in DICOM format were processed by dedicated software. The first step was the rendering of a 3D virtual model. The models were then printed. They were presented during the live surgery of the urological meeting. All the participants and the operated patients were asked to fill a questionnaire about their opinion expressed in Likert scale (1-10) about the use and application of the 3D printed models.
18 patients were enrolled, including 8 undergoing robot-assisted radical prostatectomy and 10 undergoing minimally invasive partial nephrectomy. For each patient, a virtual 3D printed model was created. The attendants rated the utility of printed models in surgical planning, anatomical representation and the role of technology in surgical training as 8/10, 10/10 and 9/10, respectively. All patients reported favorable feedbacks (from 9 to 10/10) about the use of the technology during the case discussion with the surgeon.
In our experience, 3D printing technology has been perceived as a useful tool for the purpose of surgical planning, physician education/training and patient counseling. Further researches are expected to increase the level of evidence.
测试用于机器人辅助前列腺癌和肾部分切除术之前的 3D 虚拟渲染打印模型的表面效度和内容效度。
纳入于 2017 年 1 月在一次国际泌尿外科会议上进行活体手术的患者。患有局灶性前列腺癌的患者接受机器人辅助根治性前列腺切除术。患有单个肾肿瘤的患者接受微创肾部分切除术。所有患者均接受高分辨率(HR)成像。接受肾肿瘤的患者行增强 CT 扫描加血管造影;接受前列腺癌的患者行 mp-MRI。以 DICOM 格式获取图像,并由专用软件进行处理。第一步是生成 3D 虚拟模型,然后对模型进行打印,在泌尿外科会议的活体手术中展示。所有参与者和接受手术的患者均被要求填写一份问卷,就他们对 3D 打印模型使用和应用的看法进行李克特量表(1-10 分)评分。
共纳入 18 例患者,其中 8 例行机器人辅助根治性前列腺切除术,10 例行微创部分肾切除术。为每位患者创建了一个虚拟 3D 打印模型。与会者对打印模型在手术计划、解剖学表现以及技术在手术培训中的作用的评分分别为 8/10、10/10 和 9/10。所有患者在与外科医生讨论病例时均对该技术的使用给予了好评(9-10/10)。
根据我们的经验,3D 打印技术已被认为是用于手术计划、医生教育/培训和患者咨询的有用工具。预计进一步的研究将提高证据水平。